Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
True.
But $SB*ES has stop sign and that’s been on a tear.
We need our turn.
Giddy up $CLSI
Glad I loaded more yesterday.
1.2 million total. Giddy up
Avg price .204
Completely bogus news. Big Pharma must have been complaining like hell.
Anywho, why would the FDA allow GW pharma to proceed with trials with CBD.
The FDA just contradicted themselves.
Complete bullshit.
Did you add? The only significant trade was mine
added 100k at .027
Hear ye, hear ye. You all better get your tickets for this train. Leaving the station soon. For a ride of a lifetime.
Giddy up $CLSI
We are getting there. Closer every day giddy up $CLSI.
AWESOME DD ON THIS BOARD
Indeed. Who knows. Though I do know that there is an entity taking over the shell. Filings soon. Stay tuned. Giddy up $CLSI
Awesome. Can’t wait til the filings hit. This is gonna be HUGE. Giddy up $CLSI
Definitely calm before the storm. $CLSI will soon fly to new highs. It does not make a difference if TN was barred from the securities biz. He can still be a CEO of a publicly traded entity. Fact. I know such a person that was and is running a Nasdaq listed company. There goes that theory
Agreed. Soon enough the share price will be at least 10 times higher than it is now. Patience. There is no denying that a merger is in the works. They may have stumbled getting there but we will get there. Giddy up $CLSI.
According to who? Did you actually hear this or are you guessing? We would all like to know the source of this info
$CLSI when the filings hit this will fly. Loading up on those cheap shares. Keep me coming. Giddy up
$CLSI would love to add more below .02 for the run up if I get the chance.
Even if filings were submitted incorrectly, they will be corrected. Giddy up
Excellent point! Can’t wait til $CLSI gets to new highs. Patience will be rewarded.
Soon enough we will be at new highs and stay there and above. Keep loading those cheapies. Giddy up $CLSI
We will be at new highs soon. People tried to steal your shares. We held our ground through the nonsense. Added more and away we go!
Beg to differ. They are
https://sec.report/Ticker/CLSI
This is going much higher, much to your chagrin.
I’m fresh out of the iHub jailhouse. Great DD Calvin. For those of us that have hung in here will be greatly rewarded. Filings aren’t updated for no reason. And these are not bogus filings. Giddy up. Let’s go!!
900k for me under .02
LMAO
Over 11 million offered at .0017.
Go get em
Market makers in desperate need of shares. Going higher
Management are clowns and thieves
October 28, 2019 23:46 ET
Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes
BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of $34,405,000 aggregate principal amount of its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes due 2023 (the “New 2023 Notes”). It is expected that the offering will close on or about October 31, 2019, subject to customary closing conditions.
The gross cash proceeds of approximately $29,275,000 from the offering will be used to extinguish the Company’s outstanding Convertible 3.75% Senior Notes due December 2019, pay interest upon other indebtedness, and to fund general corporate and working capital requirements.
In addition, the Company has entered into agreements with certain holders of the Company’s 4.75% Convertible Senior Notes due May 2023 (the “Existing 2023 Notes”), where such holders will exchange their Existing 2023 Notes for approximately $5,130,000 in aggregate principal amount of New 2023 Notes upon the terms of such agreements.
Interest on the New 2023 Notes will accrue at the rate of 7.0% for interest payments made in cash and at 8.0% for interest payments paid in the form of additional principal amount on such notes (“in-kind”). In each case, interest is payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2020. The New 2023 Notes mature in May 2023.
The New 2023 Notes will be convertible at the option of the holder at any time prior to maturity at an initial conversion price of $0.72 per share, subject to adjustment under certain circumstances. In the event that Teligent undergoes a “fundamental change,” holders of New 2023 Notes may require Teligent to purchase for cash all or any portion of the New 2023 Notes at the fundamental change purchase price equal to 100% of the principal amount of notes being repurchased plus accrued but unpaid interest thereon. The New 2023 Notes are not redeemable by Teligent prior to maturity.
The New 2023 Notes will be Teligent’s general senior unsecured obligations. The New 2023 Notes will be guaranteed on a senior unsecured basis by all of Teligent’s current subsidiaries that guarantee its obligations under Teligent’s senior secured credit facilities. In connection with the issuance of the New 2023 Notes, Teligent intends to enter into amendments to its senior secured credit facilities that, among other matters, will provide Teligent with the consent of the lenders to the issuance of the New 2023 Notes.
The New 2023 Notes are only being sold to qualified institutional buyers in the United States. The New 2023 Notes and any shares of common stock issuable upon conversion of the New 2023 Notes (the “Conversion Shares”) have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other jurisdiction’s securities laws, and the New 2023 Notes and the Conversion Shares may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws. Teligent does not intend to file a registration statement for the resale of the New 2023 Notes or any Conversion Shares.
Sure is
Run where. Seems to be running away
Pathetic thieves
That would leave today and tomorrow.
You can be barred from being a stockbroker and still be a CEO of a publicly traded entity. The is 100% true for sure.
Indeed. Shorts trying to grab shares
Bull. Where’s your proof
Yes golden
For now. Smh
Hmm. A lot of things are
Giddy up
Agreed. Just a major pump going on here
According to who. You?
Why isn’t LIV negating all the BS on other boards where they are truly are pumps. Amazing.
Possibly market maker signal.
On??